Nozomi MedAlliance

Japan Based Innovation Vehicle 
Accelerate the commercialization and
Approval process for Japan

Commercialization of In-house seeds  from Japan corporates  ーTheranova’s general manager and lead engineer join the team

Accelerating the approval of Theranova spin-out in Japan -Accelerate clinical and regulatory development in Japan with preferential reimbursement scheme

Starting with Cardiospire -Programmed medical device for hemodynamic and cardiopulmonary monitoring with high potential to deliver enormous healthcare cost savings to Japan

Introducing Silicon Valley Health
& Longevity Development to Japan

Daniel Burnett, MD, MBA Co-Founder & Director

Founder & CEO, Theranova (Channel Medsystems Acquired by BSX for $275M/ Sequanna Medical IPO valuation of $122M)

Robert E. Claar Co-Founder & Director

Co-Founder & CEO, HekaBio (Founder, Vorpal Technologies/ Japan regulatory approvals: 48/ Number of companies exited: 3/ Number of years in Japan: 28)

Shungo Adachi Co-Founder & Rep Director

Founder & CEO, Arc Planning Corporation (15+ yrs Advanced MED and Tech industry/ 10+ yrs Corp Dev and Executive/ Secured 10+ Licenses and Alliances  / Conducted Med-tech Distribution Channel Management of USD 150M)

Yuko Terasawa, Ph.D Co-Founder & Director

Principal Consultant, BiomedwoRx (Global Accelerator Founder/ 20+ yrs BD and scientist/ Secured 20+ strategic partnerships/ Extensive global network)